The Pharmaceutical Market: United Arab Emirates - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-13 15:24:03
The United Arab Emirates´ healthcare and pharmaceutical markets continue to be the strongest in the region. Its growth prospects are strong - we forecast high single-digit CAGRs over the course of our 10- year forecast period. Several factors are driving growth: incomes are high, as is the UAE ´ s expatriate population. These elements combine to increase private healthcare expenditure and demand for innovative drugs. Local drug production facilities are also gaining strength, with domestic player Julphar opening a new factory, and multinational drug firms are also entering the market. In addition, there are plans for several new hospital and healthcare facilities, which will boost future demand for pharmaceuticals. The UAE ´ s appeal as a medical tourism destination is another driver of growth. W e therefore remain optimistic about the growth potential of the United Arab Emirates (UAE) ´s pharmaceutical and healthcare markets.
Headline Expenditure Projections
Pharmaceuticals: AED5.56bn (US$1.51bn) in 2011 to AED5.72bn (US$1.56bn) in 2012; +2.9% in local currency and US dollar terms. Forecast unchanged from Q 4 12.
Healthcare: AED46.44bn (US$12.64bn) in 2011 to AED52.13bn (US$14.20bn) in 2012; +12.2% in local currency terms and +12.3% in US dollar terms. Forecast broadly unchanged from Q 4 12.
Medical devices: AED1.87bn (US$508mn) in 2011 to AED2.05bn (US$559mn) in 2012; +10.0% in local currency terms and +10.1% in US dollar terms. Forecast broadly unchanged from Q 4 12.
Business Environment Rating
In Q1 13, the UAE remains the most attractive market in BMI´s Middle East and Africa (MEA) Pharmaceutical Risk/Reward Ratings (RRR) matrix, with its composite score unchanged at 58.3 out of 100. The country has a favourable medium-term pharmaceutical market growth forecast.
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.